Journal Article (248)
61.
Journal Article
36 (5), p. 242 - 242 (2003)
Validation of a genetic mouse model for anxiety and comorbid depression. Pharmacopsychiatry 62.
Journal Article
36 (5), p. 245 - 245 (2003)
The roles of the endogenous cannabinoid system in learning and memory in mice. Pharmacopsychiatry 63.
Journal Article
36 (5), pp. 245 - 246 (2003)
Management of the atypical antipsychotic Olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State Hospital. Pharmacopsychiatry 64.
Journal Article
36 (5), p. 246 - 246 (2003)
Neuropsychological deficits and long-term outcomes in patients with affective disorders. Pharmacopsychiatry 65.
Journal Article
36 (5), p. 246 - 246 (2003)
Modulation of GABAergic systems with GABA agonists and antagonists, effects on sleep EEG and hormone secretion. Pharmacopsychiatry 66.
Journal Article
36 (5), p. 247 - 247 (2003)
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Pharmacopsychiatry 67.
Journal Article
36 (5), p. 249 - 249 (2003)
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress. Pharmacopsychiatry 68.
Journal Article
36 (5), p. 250 - 250 (2003)
Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium. Pharmacopsychiatry 69.
Journal Article
36 (5), p. 250 - 250 (2003)
Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression. Pharmacopsychiatry 70.
Journal Article
36 (5), pp. 250 - 251 (2003)
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP. Pharmacopsychiatry 71.
Journal Article
36 (5), p. 252 - 252 (2003)
ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders. Pharmacopsychiatry 72.
Journal Article
36 (5), pp. 252 - 253 (2003)
HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 73.
Journal Article
36 (5), p. 254 - 254 (2003)
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis. Pharmacopsychiatry 74.
Journal Article
36 (5), p. 255 - 255 (2003)
Role of chaperones in signal transduction of the glucocorticoid receptor. Pharmacopsychiatry 75.
Journal Article
36 (5), p. 256 - 256 (2003)
Influence of circadian factors on behavioral and cognitive testing in mice. Pharmacopsychiatry 76.
Journal Article
36 (5), p. 256 - 256 (2003)
Analysis of cerebrospinal fluid of depressed patients. Pharmacopsychiatry 77.
Journal Article
36 (5), p. 257 - 257 (2003)
A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation. Pharmacopsychiatry 78.
Journal Article
36 (5), p. 258 - 258 (2003)
Modulation of ligand-gated ion channels by antidepressants. Pharmacopsychiatry 79.
Journal Article
36 (5), p. 258 - 258 (2003)
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety. Pharmacopsychiatry 80.
Journal Article
36 (5), p. 261 - 261 (2003)
The youth hormone DHEA: A benefit for pathologic sleep alterations? Pharmacopsychiatry